CS276388B6 - 2- (2-Ethyl) methylphenylcarbanioylmethylthio / benzothiazole - Google Patents

2- (2-Ethyl) methylphenylcarbanioylmethylthio / benzothiazole Download PDF

Info

Publication number
CS276388B6
CS276388B6 CS904877A CS487790A CS276388B6 CS 276388 B6 CS276388 B6 CS 276388B6 CS 904877 A CS904877 A CS 904877A CS 487790 A CS487790 A CS 487790A CS 276388 B6 CS276388 B6 CS 276388B6
Authority
CS
Czechoslovakia
Prior art keywords
compound
day
invasion
ethyl
efficacy
Prior art date
Application number
CS904877A
Other languages
Czech (cs)
Slovak (sk)
Other versions
CS487790A3 (en
Inventor
Eva Ing Csc Sidoova
Jaroslav Mvdr Csc Danek
Vaclav Rndr Csc Konecny
Original Assignee
Univ Komenskeho
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Komenskeho filed Critical Univ Komenskeho
Priority to CS904877A priority Critical patent/CS276388B6/en
Publication of CS487790A3 publication Critical patent/CS487790A3/en
Publication of CS276388B6 publication Critical patent/CS276388B6/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bol připravený doteraz neznámy 2-/2-etyl-6-metylfenylkarbamoylraetyltio/ benzotiazo|. Syntáza uvedena;} zlúčeniny sa uskutečňuje Reakciou 2~usérksptobenzO“ tiazolu s H-chloracetyl-2-etyl-o-metyl“ anilínom v přítomnosti hydroxidu draselného v zmesi vody, dimetylsulfoxidu a etanolu zahriatím do varu. Zlúčenina je antihelmintioky účinná proti modelovému helmlntu Nippostrongylus brasiliensis.A previously unknown 2-[2-ethyl-6-methylphenylcarbamoylmethylthio] benzothiazole has been prepared. The synthesis of the compound is carried out by the reaction of 2-hydroxybenzothiazole with H-chloroacetyl-2-ethyl-o-methylaniline in the presence of potassium hydroxide in a mixture of water, dimethyl sulfoxide and ethanol by heating to boiling. The compound is anthelmintic effective against the model helminth Nippostrongylus brasiliensis.

Description

Predmetom vynálezu je 2-/2-etyl-6-metylfenylkarbamoylmetyltio/benzotiazol.The present invention provides 2- (2-ethyl-6-methylphenylcarbamoylmethylthio) benzothiazole.

Doteraz bol známy 2-/2,6-dimetylanilínokarboxyiBetyltio/benzotiazol, iným názvomHitherto known 2- / 2,6-dimethylanilinocarboxyethylbethylthio / benzothiazole, by another name

2-/2,6-dimetylfenylkarbsn>oylMetyltio/benzotiazol, ktorý prejavil antihélmintickú účinnost’ proti Nippostrongylus brasiliensia /Sidóová, E., Daněk, J. a Konečný, V,, čs. patent 276 322/.2- (2,6-dimethylphenylcarbonylmethylthio) benzothiazole, which has shown antihelminthic activity against Nippostrongylus brasiliensia [Sidóová, E., Daněk, J. and Konečný, V ,, čs. patent 276 322 /.

Teraz sme zistili, že doteraz neznáma zlúčenina vzorcaWe have now found that a hitherto unknown compound of the formula

ch3 je antihelminticky účinná proti modelovému belmitu Nippostrongylua brasiliensia.ch 3 is anthelmintically effective against the model belmite Nippostrongylua brasiliensia.

Súoasne bol zistený spčsob přípravy uvedenej zlúčeniny reakciou 2-merkaptobenzotiazolu s N-chlóracetyl-2-etyl-6-metylanilínom za přítomnosti hydroxidu draselného, v zmesi dimetylsulfoxidu, etanolu a vody.At the same time, a method for preparing the title compound by reacting 2-mercaptobenzothiazole with N-chloroacetyl-2-ethyl-6-methylaniline in the presence of potassium hydroxide, in a mixture of dimethyl sulfoxide, ethanol and water, was discovered.

Nasledujúce příklady bližšie oavetl'ujd, ale nijako neobmedzujú přípravu a vlastnosti zlúčeniny podl’a vynálezu.The following examples illustrate, but do not limit, the preparation and properties of the compound of the invention.

Příklad 1Example 1

Příprava 2-/2-etyl-6-metylfenylkarbamoylmetyltio/benzotiazoluPreparation of 2- (2-ethyl-6-methylphenylcarbamoylmethylthio) benzothiazole

K roztoku hydroxidů draselného /2,0 g, 0,03 mol/ vo vodě /10 cm^/ sa přidal 2-merkaptobenzotiazol /5,0 g, 0,03 mol/, potom dimetylsulfoxid /25 cm^/ a etanol /250 ctP/, Reakčná ztnes sa zahriala do vyčírenia, přidal sa k nej N-chlóracetyl-2-etyl~6-metylanilín, potom sazahriala do varu a odfarbila aktívnym uhlím. K filtrátu sa přidala 60 °C teplá voda /100 cm^/ a po oohladení na 5 °C sa z nej izoloval krystalický produkt, ktorý sa premyl dvorná dávkami /po 100 cm^/ zmesi etanol - voda v pomere 1 : 1. Získal sa čistý 2-/2-etyl-6-metylfenylkarbamoylmetyltio/benzotiazol s t.t. 157,5 až 158,0 °C v množstve 9,4 g /91,5 %/, ktorý nevyžadoval Jalsie čistanie.To a solution of potassium hydroxide (2.0 g, 0.03 mol) in water (10 cm 3) was added 2-mercaptobenzothiazole (5.0 g, 0.03 mol), followed by dimethyl sulfoxide (25 cm 3) and ethanol (250 The reaction mixture was heated to clear, N-chloroacetyl-2-ethyl-6-methylaniline was added, then boiled and decolorized with activated charcoal. To the filtrate was added 60 ° C warm water (100 cm 3) and, after cooling to 5 ° C, a crystalline product was isolated therefrom, which was washed by batches (100 cm 3) of ethanol-water 1: 1. pure 2- (2-ethyl-6-methylphenylcarbamoylmethylthio) benzothiazole with m.p. 157.5-158.0 ° C in an amount of 9.4 g (91.5%), which did not require further purification.

M.h. = 342,48 M.h. = 342.48 Pre For vypočítané % : calculated%: 0 63,13 0 63.13 H 5,30 H 5.30 N 8,18 N 8.18 S 18,72 S 18.72 zistené % : % detected: 63,25 63.25 5,25 5.25 8,07 8.07 18,45 18.45

CS 276388 B6 2CS 276388 B6 2

Příklad 2Example 2

Antihelmintická účinnost’ zláčeniny podlá vynálezu proti modelovému helmintu Nippostrongylus brasiliensisThe anthelmintic activity of the compound of the invention against the model helmint Nippostrongylus brasiliensis

Antihelmintická účinnost' bola stanovená na krysách-samcoch veku 4 až 6 týždňov a váby 120 až 140 g. Pokusná skupinu tvořilo vždy 6 krýs. 2 skupiny boli kontrolně invadované, neliečené, jedna skupina liečená štandardným preparátem levamisol a ňaťšej skupině bola aplikovaná zlúčenina podl’a vymálezu. Invázia sa vykonávala čerstvými larvami Nippostrongylus brasiliensis III. invázneho stádia v počte 500 lariev na jednu krysu. Prvá aplikácia sa vykonala v 3- déň po invázii /4. deň pokusu/, druhá aplikácia v 6. den po invázii. Vel'kost’ dávky bola 2 krát a 150 mg.kg-^· živej hmoty, Aplikácia bola vykonaná bez predchádzajúcej hladovky. Látky boli suspendované v Dorfmanovom činidle a aplikované podlá hmotnosti v objeme 0,65 až 12 ctn-\ Krysám v kontrolných neliečených skupinách bolo zhodným spúsobom aplikované per os samotné Dorfmanovo činidlo. Korpologioké vyšetrenie trusu bolo vykonané v 6. deň po inázii /7. deň pokusu/ před druhou aplikáciou testovanej látky, alebo Dorfmanovho činidla u kontrolnýoh skupin. Pokus bol ukončený hladovkou na 7. déň po invázii a zabitím krýs na 8, deň po invázii /9. deň pokusu/. Účinnost' bola vyhodnotená vykonáním helmintologickej pitvy prvých dvoch třetin tenkého čreva. Účinnost' bola vyjádřená v percentách metodou nepriamej aktivity podia Stewards.Anthelmintic activity was determined in male rats aged 4 to 6 weeks and weighing 120 to 140 g. The experimental group always consisted of 6 rats. 2 groups were control-invaded, untreated, one group treated with the standard levamisole preparation and the other group received the compound of the invention. The invasion was performed with fresh larvae of Nippostrongylus brasiliensis III. invasive stage of 500 larvae per rat. The first application was performed 3 days after the invasion / 4. day of experiment /, second application on day 6 after invasion. The dose size was 2 times and 150 mg.kg - ^ · of living matter. The application was performed without a previous fast. The substances were suspended in Dorfman's reagent and applied by weight in a volume of 0.65 to 12 ctn-1. Dorfman's reagent alone was orally administered to rats in the untreated control groups. Corpological examination of faeces was performed on day 6 after inasia / 7. day of experiment / before the second application of test substance or Dorfman's reagent in control groups. The experiment was terminated by fasting on the 7th day after the invasion and by killing the rats on the 8th day after the invasion / 9. day of experiment. Efficacy was evaluated by performing a helminth autopsy on the first two-thirds of the small intestine. Efficacy was expressed as a percentage by Stewards' indirect activity method.

Zlúčanina podl’a vynálezu prejavila účinnosť, ktorá zodpovedá 48,4 % účinnosti standardu /levamisol/.The compound of the invention showed an activity corresponding to 48.4% of the activity of the standard (levamisole).

Významný je fakt, že doteraz neznáma zlúčenina novej štruktúry prejavila účinnosť proti poměrně odolnému modelovému helmintu Nippostrongylus brasiliensis, ktorá představuje 48,4 % účinnosti štandardného preperátu levamisol. /u uvedeného modelového helmintu sa považuje za pozoruhodné účinnost’ nad 20 %/. Úalej je významný fakt, že zlúčenina podl’a vynálezu obsahuje 2-etyl~6-metylanilino-skupinu namiesto 2,6-dimetylanilíno-skupiny doteraz známého preparátu, teda obsahuje menej toxická skupinu.Significantly, the hitherto unknown compound of the new structure showed activity against the relatively resistant model helmint Nippostrongylus brasiliensis, which represents 48.4% of the activity of the standard levamisole preperate. / for said model helmint it is considered to be a remarkable efficiency ’above 20% /. It is also significant that the compound according to the invention contains a 2-ethyl-6-methylanilino group instead of the 2,6-dimethylanilino group of the hitherto known preparation, i.e. it contains a less toxic group.

Zlúčeninu podlá vynálezu možno používat' ako účinná zložku antihelmintických prípravkov samostatné, alebo v zmesi s inými látkami, alebo ako medziprodukt pře áalaie syntézy.The compound of the invention can be used as an active ingredient of anthelmintic preparations alone or in admixture with other substances, or as an intermediate in the synthesis process.

Claims (2)

CS 276388 B6 2 Příklad 2 Antihelmintická účinnost’ zlúčeniny podlá vynálezu proti modelovému helmintu Nippostrongylus brasiliensis Antihelmintická účinnost' bola stanovená na krysácb-samcoch veku 4 až 6 týždňova váhy 120 až 140 g. Pokusnú skupinu tvořilo vždy 6 krýs, 2 skupiny holi kontrolněinvadované, nelieoené, jedna skupina liečená štandardným preparátom levamisol a áať-šej skupině bola aplikovaná zlúčenina podl’a vymálezu. Invázia sa vykonávala čerstvý-mi larvami Nippostrongylus brasiliensis III. invázneho stádia v počte 500 lariev najednu krysu. Prvá aplikácia sa vykonala v 3- déň po invázii /4. den pokusu/, druháaplikácia v 6. den po invázii. Veťkosť dávky bola 2 krát a 150 mg.kg-^ živej hmoty,Aplikácia bola vykonaná bez predchádzajúeej hladovky. Látky bolí suspendované v Dorf-manovom činidle a aplikované podlá hmotnosti v objeme 0,65 až 12 cm-\ Krysám v kon-trolných neliečených skupinách bolo zhodným spésobom aplikované per os samotné Dorf-tnanovo činidlo. Korpologické vyšetrenie trusu bolo vykonané v 6, deň po inázii /7. denpokusu/ před druhou aplikáciou testovanej látky, alebo Dorfmanovho činidla u kontrol-ných skupin. Pokus bol ukončený hladovkou na 7. déň po invázii a zabitím krýs na8, deň po invázii /9. deň pokusu/. Účinnost' bola vyhodnotená vykonáním helmintologic-kej pitvy prvých dvoch třetin tenkého čreva. Účinnost' bola vyjádřená v percentáchmetodou nepriamej aktivity podlá Stewarda. Zlúčanina podl’a vynálezu prejavila účinnosť, ktorá zodpovedá 48,4 % účinnostistandardu /levamisol/. Významný je fakt, že doteraz neznáma zlúčenina novej štruktúry prejavila účinnosťproti poměrně odolnému modelovému helmintu Nippostrongylus brasiliensis, ktorá před-stavuje 48,4 % účinnosti štandardného preperátu levamisol. /u uvedeného modelovéhohelmintu sa považuje za pozoruhodné účinnost’ nad 20 %/. Úalej je významný fakt, žezlúčenina podťa vynálezu obsahuje 2-etyl-6-metylanilíno-skupinu namiesto 2,6-dimetyl-anilíno-skupiny doteraz známého preparátu, teda obsahuje menej toxická skupinu. Zlúčeninu podlá vynálezu možno používat' ako účinnú zložku antihelmintickýchprípravkov samostatné, alebo v zmesi s inýrai látkami, alebo ako medziprodukt preáaťšie syntézy. PATENTOVÉ NÁROKY 1. 2-/2-Etyl-6-metylfenylkarbamoylraetyltio/benzotiazol vzorcaExample 2 Antihelmintic activity of a compound of the invention against a model helminth Nippostrongylus brasiliensis Antihelmintic activity was determined on male rats 4 to 6 weeks of age weighing 120 to 140 g. , one group treated with a standard preparation of levamisole and a larger group was administered the compound according to the invention. Invasion was performed with fresh larvae of Nippostrongylus brasiliensis III. invasive stage of 500 rat larvae. The first application was performed at 3- day after invasion / 4. day of experiment /, second application on day 6 after invasion. The dose size was 2 times and 150 mg / kg bodyweight, The application was carried out without a hunger strike. The substances were suspended in the Dorf-mann reagent and applied according to the weight in the volume of 0.65 to 12 cm- The rats in the control untreated groups were equally applied per os on the Dorftan reagent alone. The faecal examination of the faeces was performed at 6, day after inactivity / 7. the test / before the second application of the test substance, or the Dorfman reagent in the control groups. The experiment was terminated by hunger strike at 7 days after invasion and killing of rats at 8, day after invasion / 9. day of experiment /. Efficacy was assessed by performing helmintological dissection of the first two thirds of the small intestine. Efficiency was expressed as a percentage of the method of indirect activity according to Steward. The compound of the invention exhibited an efficacy equivalent to 48.4% of the efficacy standard (levamisole). Significant is the fact that the hitherto unknown compound of the new structure has shown efficacy against the relatively resistant Nippostrongylus brasiliensis model helminth, which represents 48.4% of the efficacy of the standard levamisole preperate. / for the model model, it is considered to be a remarkable efficiency above 20% /. Furthermore, it is important that the compound of the invention contains 2-ethyl-6-methylanilino-group instead of 2,6-dimethyl-anilino-group, hitherto known to contain a less toxic group. The compound of the present invention can be used as an active ingredient of antihelmintic preparations alone or in admixture with an inert agent, or as an intermediate for past synthesis. Claims 1. 2- / 2-Ethyl-6-methylphenylcarbamoylraethylthio / benzothiazole Formula X \ ^C-S-CHg-CO-NH·X-C-S-CHg-CO-NH · 2. Spésob přípravy zlúčeniny podťa bodu 1, vyznačený tým, že sa nechá reagovat' 2-mer-kaptobenzotiazol s N-chlóracetyl—2-etyl-6~metylanilínom za přítomnosti hydroxidudraselného v zmesi vody, dimetylsulfoxidu a anilínu zahriatím do varu.2. A process for the preparation of a compound according to claim 1, characterized in that 2-mercaptobenzothiazole is reacted with N-chloroacetyl-2-ethyl-6-methylaniline in the presence of potassium hydroxide in a mixture of water, dimethyl sulfoxide and aniline by heating to boiling.
CS904877A 1990-10-08 1990-10-08 2- (2-Ethyl) methylphenylcarbanioylmethylthio / benzothiazole CS276388B6 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS904877A CS276388B6 (en) 1990-10-08 1990-10-08 2- (2-Ethyl) methylphenylcarbanioylmethylthio / benzothiazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS904877A CS276388B6 (en) 1990-10-08 1990-10-08 2- (2-Ethyl) methylphenylcarbanioylmethylthio / benzothiazole

Publications (2)

Publication Number Publication Date
CS487790A3 CS487790A3 (en) 1992-05-13
CS276388B6 true CS276388B6 (en) 1992-05-13

Family

ID=5392501

Family Applications (1)

Application Number Title Priority Date Filing Date
CS904877A CS276388B6 (en) 1990-10-08 1990-10-08 2- (2-Ethyl) methylphenylcarbanioylmethylthio / benzothiazole

Country Status (1)

Country Link
CS (1) CS276388B6 (en)

Also Published As

Publication number Publication date
CS487790A3 (en) 1992-05-13

Similar Documents

Publication Publication Date Title
DE2527065A1 (en) 5-PROPYLTHIO-2-BENZIMIDAZOLE CARBAMIC ACID METHYLESTER
DE2160946B2 (en) aminocarboxamides and medicaments containing these compounds
EP0221781A2 (en) Benzylamine derivatives, process for production thereof, and use thereof
DE2638553A1 (en) THIAZOLINYLBENZIMIDAZOLE
DE1620449B2 (en) SUBSTITUTED BENZIMIDAZOLES AND METHOD FOR PREPARING IT
EP0070084A2 (en) Imidazoline derivatives
DE2733291A1 (en) (3-AMINO-5-SUBSTITUTED-6-FLUORPYRAZINOYL- OR -PYRAZINAMIDO) GUANIDINE AND THEIR DERIVATIVES SUBSTITUTED TO GUANIDINO NITROGEN
CS276388B6 (en) 2- (2-Ethyl) methylphenylcarbanioylmethylthio / benzothiazole
US4336262A (en) Pour-on veterinary anthelmintic
DE1620117A1 (en) Process for the preparation of 5-nitroimidazole derivatives
CH645368A5 (en) 2-HYDROXY-5- (1-HYDROXY-2-PIPERAZINYLETHYL) BENZOESIC ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF.
DE2166359A1 (en) RECTANGULAR CLIP ON (4-ACYLAMIDOPHENOXY) -ALKYL RECTANGULAR CLIP FOR -AETHER AND A METHOD FOR MAKING IT
US4187305A (en) Procedure for treating mammals to control parasitic diptera larvae
EP0177054B1 (en) Pyridine derivatives, processes for their preparation and pharmaceutical compositions containing them
CS276322B6 (en) 2- / 2,6-Dimetylanilínokarhoxymetyltio / benzothiazol
DE2736268A1 (en) NEW 5-THIAZOLE ALKYLAMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF
CS271750B1 (en) N-maleoyl-2,6-diethylaniline
US4263324A (en) Anticoccidial and ovolarvicidal compositions
CS276317B6 (en) 6-salicylideneamino-2-benzotiazolíntion
CA2014346A1 (en) Bis- (pyrrolidonyl alkylene) biguanides
DE2014293A1 (en) Substituted benzimidazoles and processes for their preparation and use
DE1695849A1 (en) Process for the preparation of new pyrimidine derivatives
US3578711A (en) N-(3,4-dichlorophenyl) - 3-(n'-(3,4-dichlorophenyl) carbamoyl)methyl - 2,2 - dimethylcyclobutane carboxamide
DE1951259A1 (en) Substituted 5-nitroimidazoles and processes for their preparation
AT236941B (en) Process for the preparation of new substituted benzimidazoles and their acid addition salts